IBDEI1K3 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24874,0)
 ;;=D05.82^^107^1211^35
 ;;^UTILITY(U,$J,358.3,24874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24874,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,24874,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,24874,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,24875,0)
 ;;=D05.81^^107^1211^37
 ;;^UTILITY(U,$J,358.3,24875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24875,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,24875,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,24875,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,24876,0)
 ;;=D05.80^^107^1211^39
 ;;^UTILITY(U,$J,358.3,24876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24876,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,24876,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,24876,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,24877,0)
 ;;=D56.8^^107^1211^191
 ;;^UTILITY(U,$J,358.3,24877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24877,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,24877,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,24877,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,24878,0)
 ;;=C82.89^^107^1211^77
 ;;^UTILITY(U,$J,358.3,24878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24878,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,24878,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,24878,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,24879,0)
 ;;=D51.8^^107^1211^198
 ;;^UTILITY(U,$J,358.3,24879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24879,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,24879,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,24879,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,24880,0)
 ;;=I80.9^^107^1211^183
 ;;^UTILITY(U,$J,358.3,24880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24880,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,24880,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,24880,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,24881,0)
 ;;=D45.^^107^1211^184
 ;;^UTILITY(U,$J,358.3,24881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24881,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,24881,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,24881,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,24882,0)
 ;;=C77.3^^107^1211^113
 ;;^UTILITY(U,$J,358.3,24882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24882,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,24882,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,24882,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,24883,0)
 ;;=C77.2^^107^1211^129
 ;;^UTILITY(U,$J,358.3,24883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24883,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,24883,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,24883,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,24884,0)
 ;;=C77.1^^107^1211^130
 ;;^UTILITY(U,$J,358.3,24884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24884,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,24884,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,24884,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,24885,0)
 ;;=C77.0^^107^1211^146
 ;;^UTILITY(U,$J,358.3,24885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24885,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,24885,1,4,0)
 ;;=4^C77.0
